These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17005830)

  • 21. Fluoroquinolone resistance and molecular characterization of gyrA and parC quinolone resistance-determining regions in Escherichia coli isolated from poultry.
    Vanni M; Meucci V; Tognetti R; Cagnardi P; Montesissa C; Piccirillo A; Rossi AM; Di Bello D; Intorre L
    Poult Sci; 2014 Apr; 93(4):856-63. PubMed ID: 24706962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resident microbial communities inhibit growth and antibiotic-resistance evolution of Escherichia coli in human gut microbiome samples.
    Baumgartner M; Bayer F; Pfrunder-Cardozo KR; Buckling A; Hall AR
    PLoS Biol; 2020 Apr; 18(4):e3000465. PubMed ID: 32310938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between mutant prevention concentrations and mutation frequencies against enrofloxacin for avian pathogenic Escherichia coli isolates.
    Ozawa M; Asai T
    J Vet Med Sci; 2013; 75(6):709-13. PubMed ID: 23328636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns.
    Takahashi A; Muratani T; Yasuda M; Takahashi S; Monden K; Ishikawa K; Kiyota H; Arakawa S; Matsumoto T; Shima H; Kurazono H; Yamamoto S
    J Clin Microbiol; 2009 Mar; 47(3):791-5. PubMed ID: 19158256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fluoroquinolone-resistant Escherichia coli clinical isolate without quinolone resistance-determining region mutations found in Japan.
    Sato T; Yokota S; Uchida I; Okubo T; Ishihara K; Fujii N; Tamura Y
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3964-5. PubMed ID: 21670180
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.
    Mendes RE; Bell JM; Turnidge JD; Yang Q; Yu Y; Sun Z; Jones RN
    Antimicrob Agents Chemother; 2008 Feb; 52(2):798-9. PubMed ID: 18086850
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
    Yamane K; Wachino J; Suzuki S; Arakawa Y
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1564-6. PubMed ID: 18285488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
    Sato T; Yokota S; Okubo T; Ishihara K; Ueno H; Muramatsu Y; Fujii N; Tamura Y
    J Vet Med Sci; 2013 May; 75(4):407-14. PubMed ID: 23149545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Mismatch Amplification Mutation Assay PCR and PCR-Restriction Fragment Length Polymorphism for Detection of Major Mutations in gyrA and parC of Escherichia coli Associated with Fluoroquinolone Resistance.
    Jazeela K; Chakraborty G; Shetty SS; Rohit A; Karunasagar I; Vijaya Kumar D
    Microb Drug Resist; 2019; 25(1):23-31. PubMed ID: 30036132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones.
    Han JH; Nachamkin I; Tolomeo P; Mao X; Bilker WB; Lautenbach E
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):491-6. PubMed ID: 23719087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
    Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
    Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental Evolution of Escherichia coli K-12 in the Presence of Proton Motive Force (PMF) Uncoupler Carbonyl Cyanide
    Griffith JM; Basting PJ; Bischof KM; Wrona EP; Kunka KS; Tancredi AC; Moore JP; Hyman MRL; Slonczewski JL
    Appl Environ Microbiol; 2019 Mar; 85(5):. PubMed ID: 30578262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First characterization of fluoroquinolone resistance mechanisms in CTX-M-producing Escherichia coli from Mongolia.
    Kao CY; Udval U; Wu HM; Bolormaa E; Yan JJ; Khosbayar T; Wu JJ
    Infect Genet Evol; 2016 Mar; 38():79-81. PubMed ID: 26692472
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased survival of antibiotic-resistant Escherichia coli inside macrophages.
    Miskinyte M; Gordo I
    Antimicrob Agents Chemother; 2013 Jan; 57(1):189-95. PubMed ID: 23089747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.